Results of Cervical Segmental Mobilization in Patients With Chronic Lateral Epicondylitis

NCT ID: NCT06440928

Last Updated: 2024-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-15

Study Completion Date

2024-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of our study was to investigate the effect of cervical segmental mobilization on pain, functionality, grip strength and quality of life in patients with chronic lateral epicondylitis. It was planned as a randomized controlled experimental study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epicondylitis of the Elbow Servical Segmental Mobilization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomised controlled and experimental study
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention grup: standart treatment and segmental mobilization grup

Mobilisation specifically on the C7 segment will be performed by the physiotherapist 2 times a week for 3 weeks, making decisions on the choice of key parameters including treatment technique, spinal level, degree, direction, side and duration.

Group Type EXPERIMENTAL

mobilization

Intervention Type BEHAVIORAL

mobilization and exercise to be applied to patients with chronic lateral epicondylitis

standard treatment

Intervention Type OTHER

standard treatment

intervention grup : standart treatment and deep friction

The patients were asked to stretch for 20 s with the other hand with the shoulder in internal rotation, elbow in extension, forearm in pronation, wrist in flexion and ulnar deviation. In the first week, stretching exercises were recommended to be performed 3 sets a day, 5⨯20 s in one set and 45 s rest interval before strengthening exercises. The application will be performed with the thumb in the transverse direction, with the pressure tolerated by the individual, for 10 minutes after numbness is obtained, the treatment lasts approximately 10-15 minutes.

Group Type EXPERIMENTAL

standard treatment

Intervention Type OTHER

standard treatment

deep friction

Intervention Type OTHER

deep friction

intervention grup: standart treatment.

The patients were asked to stretch for 20 s with the other hand with the shoulder in internal rotation, elbow in extension, forearm in pronation, wrist in flexion and ulnar deviation. In the first week, stretching exercises were recommended to be performed 3 sets a day, 5⨯20 s in one set and 45 s rest interval before strengthening exercises. Starting from the 2nd week of treatment, it will be requested to be performed 3 sets a day, 5⨯20 s in one set, 5⨯20 s before exercise and 5⨯20 s after exercise.

Group Type EXPERIMENTAL

standard treatment

Intervention Type OTHER

standard treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mobilization

mobilization and exercise to be applied to patients with chronic lateral epicondylitis

Intervention Type BEHAVIORAL

standard treatment

standard treatment

Intervention Type OTHER

deep friction

deep friction

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

excersize

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being between the ages of 25-44
* Being diagnosed with LE by a physician
* Not having any defined pathology in the cervical region
* No neurological problems in the upper extremities
* No history of cervical surgery

Exclusion Criteria

* Those with a history of infection, tumor, trauma in the cervical area
* Fibromyalgia patients
* Congenital or acquired deformities of the upper extremity
* History of shoulder or elbow surgery or dislocation
* Cervical radiculopathy
* Having had Wiplash
Minimum Eligible Age

25 Years

Maximum Eligible Age

44 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Halic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mustafa Yığılıtaş

lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yalova University

Yalova, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

mustafa yığılıtaş, doctorate

Role: CONTACT

05309782720

seda saka, asst.prof

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mustafa Yığılıtaş, Doctorate

Role: primary

05309782720

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/106

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.